Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04650542 · ClinicalTrials.gov registry record · Phase 1
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
A Phase 1 study, sponsored by HUYABIO International.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT04650542 is a Phase 1 study that has completed, run by HUYABIO International. The registered enrollment target is 39 participants.
The verdict
NCT04650542, a Phase 1 study, has completed, sponsored by HUYABIO International.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
Interventions
- DRUG Paroxetine
- DRUG HBI-3000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-02-21 |
| Est. Completion | 2021-08-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04650542
The ClinicalTrials.gov registry entry for NCT04650542 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HUYABIO International, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paroxetine is the first listed.
NCT04650542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04650542 about?
NCT04650542 is a clinical study titled "Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects". Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
What is the current status of trial NCT04650542?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2021-02-21. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT04650542?
The interventions under investigation include: Paroxetine (DRUG), HBI-3000 (DRUG).
Who is sponsoring clinical trial NCT04650542?
This trial is sponsored by HUYABIO International, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.